$1.27
$0.00 (0.00%)
End-of-day quote: 05/31/2024
NasdaqCM:NKTR
Nektar Therapeutics Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$90.12M | $92.06M | $101.91M | $152.92M | $114.62M | $1.19B | $307.71M | $165.44M | $230.78M | $200.71M | $148.92M | $81.19M | $71.48M | $159.04M | $71.93M | $90.19M | $273.03M | $217.72M | $126.28M | $114.27M | |
| GM % | Gross Margin % |
|
62.53% | 76.50% | 75.57% | 87.26% | 81.35% | 97.95% | 90.07% | 81.74% | 85.22% | 85.78% | 74.14% | 62.52% | 69.37% | 83.86% | 56.98% | 62.67% | 46.33% | 45.76% | 71.49% | 82.67% | |
| OM | Operating Margin |
|
-150.05% | -260.97% | 0.00% | -248.45% | 0.00% | 57.65% | -14.19% | -68.22% | -12.73% | -8.21% | -80.67% | -171.85% | -169.61% | -9.86% | -132.25% | -161.66% | -28.77% | -60.68% | -86.66% | -64.71% | |
| EPS | Earnings Per Share |
|
$0.00 | $-0.86 | $-1.97 | $-2.86 | $-2.49 | $-2.52 | $3.78 | $-0.62 | $-1.10 | $-0.51 | $-0.42 | $-1.40 | $-1.48 | $-1.19 | $-0.27 | $-1.11 | $-0.37 | $-0.81 | $-1.22 | $-1.30 | $-1.01 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0.00% | 0 | 0 | 0 | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0 | -0.00% | -0.00% | -0.00% | 0 | |
| Sha. | Shares |
|
191.38m | 188.56m | 185.47m | 180.09m | 176.51m | 173.53m | 159.52m | 153.21m | 135.29m | 131.22m | 116.49m | 115.26m | 114.49m | 94.52m | 93.28m | 92.5m | 92.3m | 91.28m | 87.71m | 84.57m | |
| OCF | Operating Cash Flow |
|
$-192.61M | $-304.01M | $-412.66M | $-313.29M | $-328.68M | $718.21M | $-80.41M | $-117.02M | $-73.08M | $-142.01M | $-38.53M | $-129.76M | $-113.74M | $-55.87M | $39.74M | $-145.78M | $146.30M | $-92.72M | $-78.00M | $-78.14M | |
| FCF | Free Cash Flow |
|
$-281.00M | $-309.68M | $-427.65M | $-320.55M | $-354.97M | $706.61M | $-90.09M | $-123.42M | $-84.28M | $-151.98M | $-42.62M | $-140.34M | $-123.46M | $-87.33M | $19.04M | $-164.64M | $113.50M | $-115.24M | $-95.96M | $-105.33M | |
| FCFS | Free Cash Flow Per Share |
|
$-1.02 | $-1.65 | $-2.33 | $-1.79 | $-2.03 | $4.15 | $-0.58 | $-0.88 | $-0.64 | $-1.20 | $-0.37 | $-1.22 | $-1.09 | $-0.93 | $0.21 | $-1.78 | $1.24 | $-1.28 | $-1.12 | $-1.34 |
